Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Lacorazza

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
Frontiers in Oncology|December 24, 2024
Pharmacological inhibition of the MAP2K7 kinase in human diseaseH Daniel Lacorazza
Frontiers in Immunology|July 1, 2025
The reprogramming factor KLF4 in normal and malignant blood cellsH Daniel Lacorazza
Oncotarget|November 2, 2017
KLF4 represses MAP2K7 signaling in T-ALLH Daniel Lacorazza
Current Cancer Drug Targets|May 28, 2014
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?Koramit Suppipat, H Daniel Lacorazza
Frontiers in Immunology|September 3, 2025
Editorial: Exploring KLF4's role in immune cell function and disease progressionH Daniel Lacorazza, Walden Ai
Blood Cells, Molecules & Diseases|November 26, 2003
The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesisH Daniel Lacorazza, Stephen D Nimer
Methods in Molecular Biology (Clifton, N.J.)|October 15, 2017
Retroviral Transduction of Quiescent Murine Hematopoietic Stem CellsChun Shik Park, H Daniel Lacorazza
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Exclusion and inclusion of TCR alpha proteins during T cell development in TCR-transgenic and normal miceH Daniel Lacorazza, Janko Nikolich-Zugich
Experimental & Molecular Medicine|October 17, 2020
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cellsChun Shik Park, H Daniel Lacorazza
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Frontiers in Oncology|December 24, 2024
Pharmacological inhibition of the MAP2K7 kinase in human diseaseH Daniel Lacorazza
Frontiers in Immunology|July 1, 2025
The reprogramming factor KLF4 in normal and malignant blood cellsH Daniel Lacorazza
Oncotarget|November 2, 2017
KLF4 represses MAP2K7 signaling in T-ALLH Daniel Lacorazza
Current Cancer Drug Targets|May 28, 2014
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?Koramit Suppipat, H Daniel Lacorazza
Frontiers in Immunology|September 3, 2025
Editorial: Exploring KLF4's role in immune cell function and disease progressionH Daniel Lacorazza, Walden Ai
Blood Cells, Molecules & Diseases|November 26, 2003
The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesisH Daniel Lacorazza, Stephen D Nimer
Methods in Molecular Biology (Clifton, N.J.)|October 15, 2017
Retroviral Transduction of Quiescent Murine Hematopoietic Stem CellsChun Shik Park, H Daniel Lacorazza
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Exclusion and inclusion of TCR alpha proteins during T cell development in TCR-transgenic and normal miceH Daniel Lacorazza, Janko Nikolich-Zugich
Experimental & Molecular Medicine|October 17, 2020
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cellsChun Shik Park, H Daniel Lacorazza
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Pageof 5